Global Human Chorionic Gonadotropin Market Report By Technology(Natural Source Extraction And Recombinant Technology), By Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment And Others), By End-User (Fertility Clinics, Research Institution And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2028

Name: Global Human Chorionic Gonadotropin Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11210347

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

As per this study, the Global Human Chorionic Gonadotropin Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2028 with a CAGR of XX%.

Human chorionic gonadotropin as HCG is the placental hormone secreted by the placental cells in pregnancy immediately after implantation. HCG stimulates egg secretion during ovulation and also helps to treat infertility in female and increase sperm count in the male population. Presence of HCG is detected in urine or blood sample of pregnant female.

Market Dynamics

The rising prevalence of infertility among both female and male population is the major driver driving the market growth. Increasing cases with polycystic ovary syndrome, endometriosis, hypogonadism, oligospermia, and other hormonal disorders are further pushing the market demand. Also, changing lifestyle, improper eating habits and increased maternity age are some of the prominent factors boosting the market demand. In addition to this, increasing awareness regarding HCG hormone treatment by medical professionals is likely to upsurge the market growth.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis, and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of human chorionic gonadotropin.

Market Segmentation

The broad human chorionic gonadotropin market has been sub-grouped into type, application, and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Technology

Natural Source Extraction
Recombinant Technology

By Therapeutic Area

Female Infertility Treatment
Male Hypogonadism
Oligospermic Treatment
Others

By End-User

Fertility Clinics
Research Institution
Others

Regional Analysis

Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for human chorionic gonadotropinin North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Global Human Chorionic Gonadotropin Market Share by Region (Representative Graph)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the human chorionic gonadotropin market include Bristol Myers Squibb Company, Cigna, Ferring B.V., Fresenius Kabi AG, Lee BioSolutions, Inc., Lupin, Merck & Co., Inc., Sanzyme, Scripps Laboratories and Sun Pharmaceutical Industries Ltd. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Human Chorionic Gonadotropin Market
       2.2. Global Human Chorionic Gonadotropin Market Snapshot

3 . HUMAN CHORIONIC GONADOTROPIN – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Human Chorionic Gonadotropin Market
       3.3. Market Restraints of Human Chorionic Gonadotropin Market
       3.4. Opportunities of Human Chorionic Gonadotropin Market
       3.5. Trends of Human Chorionic Gonadotropin Market
       3.6. Porter’s Five Force Analysis of Human Chorionic Gonadotropin Market
       3.7. Human Chorionic Gonadotropin Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by By Technology
           3.7.2 Market Attractive Analysis by By Therapeutic Area
           3.7.3 Market Attractive Analysis by By End-User
           3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Human Chorionic Gonadotropin Value Chain Analysis
       4.2. Human Chorionic Gonadotropin Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Human Chorionic Gonadotropin Raw Material Manufactures List
           4.2.3. Price Trend of Human Chorionic Gonadotropin Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL HUMAN CHORIONIC GONADOTROPIN MARKET ANALYSIS BY BY TECHNOLOGY
       5.1 Overview by By Technology
       5.2 Global Human Chorionic Gonadotropin Market Analysis by By Technology
       5.3 Market Analysis of Natural Source Extraction by Regions
       5.4 Market Analysis of Recombinant Technology by Regions

6 . GLOBAL HUMAN CHORIONIC GONADOTROPIN MARKET ANALYSIS BY BY THERAPEUTIC AREA
       6.1 Overview by By Therapeutic Area
       6.2 Global Human Chorionic Gonadotropin Market Analysis by By Therapeutic Area
       6.3 Market Analysis of Female Infertility Treatment by Regions
       6.4 Market Analysis of Male Hypogonadism by Regions
       6.5 Market Analysis of Oligospermic Treatment by Regions
       6.6 Market Analysis of Others by Regions

7 . GLOBAL HUMAN CHORIONIC GONADOTROPIN MARKET ANALYSIS BY BY END-USER
       7.1 Overview by By End-User
       7.2 Global Human Chorionic Gonadotropin Market Analysis by By End-User
       7.3 Market Analysis of Fertility Clinics by Regions
       7.4 Market Analysis of Research Institution by Regions
       7.5 Market Analysis of Others by Regions

8 . GLOBAL HUMAN CHORIONIC GONADOTROPIN MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
         8.3.1. Overview
           8.3.2. North America Human Chorionic Gonadotropin Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Human Chorionic Gonadotropin Market Estimate by Market Segment
           8.4.3. Europe Human Chorionic Gonadotropin Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Human Chorionic Gonadotropin Market Estimate by Market Segment
           8.5.3. Asia Pacific Human Chorionic Gonadotropin Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Human Chorionic Gonadotropin Market Estimate by Market Segment
           8.6.3. Latin America Human Chorionic Gonadotropin Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Human Chorionic Gonadotropin Market Estimate by Market Segment
           8.7.3. Middle East & Africa Human Chorionic Gonadotropin Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE HUMAN CHORIONIC GONADOTROPIN COMPANIES
       9.1. Human Chorionic Gonadotropin Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF HUMAN CHORIONIC GONADOTROPIN INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Bristol Myers Squibb Company
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Cigna
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Ferring B.V.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Fresenius Kabi AG
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Lee BioSolutions, Inc.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Lupin
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Merck & Co., Inc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Sanzyme
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Scripps Laboratories
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Sun Pharmaceutical Industries Ltd.
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK
11.1. Impact Analysis of Covid-19 Outbreak on the Market
11.1.1. Direct Impact on Production
11.1.2. Supply Chain and Market Disruption
11.1.3. Financial Impact on Firms and Financial Markets
11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
11.3. Pre V/S Post COVID-19 Market
11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
11.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Human Chorionic Gonadotropin Report
Market Research Process
Market Research Methodology
Global Human Chorionic Gonadotropin Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by By Technology
Market Attractiveness Analysis by By Therapeutic Area
Market Attractiveness Analysis by By End-User
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Human Chorionic Gonadotropin Market Analysis by By Technology (USD MN)
Global Human Chorionic Gonadotropin Market Analysis in Natural Source Extraction by Geography (USD MN)
Global Human Chorionic Gonadotropin Market Analysis in Recombinant Technology by Geography (USD MN)
Global Human Chorionic Gonadotropin Market Analysis by By Therapeutic Area (USD MN)
Global Human Chorionic Gonadotropin Market Analysis in Female Infertility Treatment by Geography (USD MN)
Global Human Chorionic Gonadotropin Market Analysis in Male Hypogonadism by Geography (USD MN)
Global Human Chorionic Gonadotropin Market Analysis in Oligospermic Treatment by Geography (USD MN)
Global Human Chorionic Gonadotropin Market Analysis in Others by Geography (USD MN)
Global Human Chorionic Gonadotropin Market Analysis by By End-User (USD MN)
Global Human Chorionic Gonadotropin Market Analysis in Fertility Clinics by Geography (USD MN)
Global Human Chorionic Gonadotropin Market Analysis in Research Institution by Geography (USD MN)
Global Human Chorionic Gonadotropin Market Analysis in Others by Geography (USD MN)
Latin America Human Chorionic Gonadotropin Market by Revenue
Middle East & Africa Human Chorionic Gonadotropin Market by Revenue
Recent Development in Human Chorionic Gonadotropin Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "